Online citations, reference lists, and bibliographies.
← Back to Search

Sodium Hyaluronate Gels As A Drug‐release System For Corticosteroids: Release Kinetics And Antiproliferative Potential For Glaucoma Surgery

M. Spitzer, E. Yoeruek, R. Kaczmarek, A. Sierra, S. Aisenbrey, S. Grisanti, K. Bartz-Schmidt, Peter Szurman
Published 2008 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
Purpose:  To evaluate the release kinetics, biocompatibility and antiproliferative potential of a concentrated hydrophilic steroid formulation from commercially available sodium hyaluronate gels as a potential adjunct in glaucoma surgery.
This paper references
10.1016/S0161-6420(02)01739-6
Clinical characteristics and leakage of functioning blebs after trabeculectomy with mitomycin-C in primary glaucoma patients.
Chao-Yu Hu (2003)
10.1002/JPS.2600521210
MECHANISM OF SUSTAINED-ACTION MEDICATION. THEORETICAL ANALYSIS OF RATE OF RELEASE OF SOLID DRUGS DISPERSED IN SOLID MATRICES.
T. Higuchi (1963)
Effect of sodium hyaluronate
DG Charties (1991)
10.1016/S0002-9394(14)73465-8
Clinical and histopathologic observations concerning hypotony after trabeculectomy with adjunctive mitomycin C.
M. B. Shields (1993)
Effect of steroids and nonsteroidal antiinflammatory agents on human ocular fibroblast.
K. Nguyen (1992)
10.1097/00061198-200110001-00029
Advances in glaucoma surgery: evolution of antimetabolite adjunctive therapy.
P. Khaw (2001)
Subconjunctival sodium hyaluornate 2.3% in trabeculectomy. A prospective randomized clinical trial
JF Lopes (2006)
10.1001/ARCHOPHT.116.3.286
Outcomes of primary trabeculectomy with the use of adjunctive mitomycin.
I. Scott (1998)
10.1081/DDC-100102137
In vitro release kinetics of gentamycin from a sodium hyaluronate gel delivery system suitable for the treatment of peripheral vestibular disease.
R. M. Kelly (1999)
Clinical and histopathologic observation concerning hypotony after trabeculectomy with adjunctive mito - mycin C
HH Sigurdsson (2007)
10.1001/ARCHOPHT.1983.01040010795021
Histologic characteristics of filtering blebs in glaucomatous eyes.
E. Addicks (1983)
10.1016/S0161-6420(00)00391-2
Trabeculectomy with intraoperative mitomycin C versus 5-fluorouracil. Prospective randomized clinical trial.
K. Singh (2000)
10.1074/JBC.M102273200
Differential Involvement of the Hyaluronan (HA) Receptors CD44 and Receptor for HA-mediated Motility in Endothelial Cell Function and Angiogenesis*
R. Savani (2001)
10.1136/bjo.2003.027573
Sodium hyaluronate (hyaluronic acid) promotes migration of human corneal epithelial cells in vitro
J. A. P. Gomes (2004)
10.1097/00132578-200104000-00018
Risk factors for development of post-trabeculectomy endophthalmitis.
O. Lehmann (2000)
Effect of sodium hyaluronate on trabeculectomy filtration blebs.
D. Charteris (1991)
10.1016/0014-4827(89)90428-X
The effect of hyaluronate and its oligosaccharides on endothelial cell proliferation and monolayer integrity.
D. West (1989)
Clinical and histopathologic observation concerning hypotony
MB Shields (1993)
10.1016/S0886-3350(01)01092-6
Stabilization of flat anterior chamber after trabeculectomy with Healon5.
R. S. Hoffman (2002)
10.1089/108076802760116179
A comparative study of effects of antiproliferative drugs on human retinal pigment epithelial cells in vitro.
W. Wu (2002)
Effects of steroids and nonsteroidal anti-inflammatory agents on human ocular fibroblasts
KD Nguyen (1992)
A prospective, randomized clinical trial
G. Beldi (2004)
10.1016/J.OPHTHA.2006.01.040
Subconjunctival sodium hyaluronate 2.3% in trabeculectomy: a prospective randomized clinical trial.
J. F. Lopes (2006)
10.3928/1542-8877-19861101-06
Sodium hyaluronate (Healon) in glaucoma filtering procedures.
J. Alpar (1986)
10.1097/00061198-199400320-00002
Intraoperative intracameral viscoelastic agent in the prevention of postfiltration flat anterior chamber.
M. Wand (1994)
10.1016/S0161-6420(92)31951-7
Intraoperative mitomycin versus postoperative 5-fluorouracil in high-risk glaucoma filtering surgery.
G. L. Skuta (1992)
10.1016/J.EXER.2006.02.012
Differential toxic effect of dissolved triamcinolone and its crystalline deposits on cultured human retinal pigment epithelium (ARPE19) cells.
Peter Szurman (2006)
10.1111/J.1600-0420.2007.00885.X
Topical and systemic absorption in delivery of dexamethasone to the anterior and posterior segments of the eye.
H. Sigurdsson (2007)
Novel drug delivery systems, 2nd edn
YW Chien (1992)
10.1016/S0002-9394(98)00115-9
Adjunctive daunorubicin in the treatment of proliferative vitreoretinopathy: results of a multicenter clinical trial. Daunomycin Study Group.
P. Wiedemann (1998)
10.1001/ARCHOPHT.1988.01060130095036
Cellular proliferation after experimental glaucoma filtration surgery.
H. Jampel (1988)
10.3928/1542-8877-19880701-15
Viscoelastic agent and the prevention of post-filtration flat anterior chamber.
M. Wand (1988)



This paper is referenced by
Modulation of Inflammation Driven Wound Healing after Glaucoma Surgery
J. J. Armstrong (2019)
10.1159/000320077
Cystoid macular edema in uveitis.
M. D. de Smet (2010)
10.3892/etm.2012.629
Sodium hyaluronate as a drug-release system for VEGF 165 improves graft revascularization in anterior cruciate ligament reconstruction in a rabbit model
J. Chen (2012)
Design of Novel Antigen-Specific Immunotherapies for the Treatment of Autoimmune Disorders
Chad J Pickens (2017)
10.1007/s00347-015-0057-z
Künstlicher Glaskörper
Siegfried Mariacher (2015)
10.1007/s00347-015-0057-z
[Artificial vitreous body: Strategies for vitreous body substitutes].
S. Mariacher (2015)
10.3109/02713683.2012.658593
Biocompatibility and Antifibrotic Effect of UV-Cross-Linked Hyaluronate as a Release-System for Tranilast after Trabeculectomy in a Rabbit Model—a Pilot Study
M. Spitzer (2012)
10.1159/000381865
Dexamethasone Intravitreal Implant as Adjunctive Therapy to Ranibizumab in Neovascular Age-Related Macular Degeneration: A Multicenter Randomized Controlled Trial
B. Kuppermann (2015)
10.5005/jp-journals-10008-1160
Wound Healing Modulation in Glaucoma Filtration Surgery– Conventional Practices and New Perspectives: Antivascular Endothelial Growth Factor and Novel Agents (Part II)
Jennifer C Fan Gaskin (2014)
OPTH_A_224456 2403..2409
Cagdas Kaya (2019)
10.1167/iovs.11-7573
Effects of gelatin hydrogel containing chymase inhibitor on scarring in a canine filtration surgery model.
S. Kojima (2011)
10.1016/j.mehy.2012.09.019
The triblock copolymers hydrogel through intracameral injection may be a new potential ophthalmic drug delivery with antiscarring drugs after glaucoma filtration surgery.
Y. Qiao (2013)
10.2147/OPTH.S224456
Adding a Corticosteroid or Switching to Another Anti-VEGF in Insufficiently Responsive Wet Age-Related Macular Degeneration
Cagdas Kaya (2019)
10.3390/ma5101986
Solvent Composition is Critical for Carbodiimide Cross-Linking of Hyaluronic Acid as an Ophthalmic Biomaterial
J. Lai (2012)
10.1007/978-2-8178-0118-6_8
Œdème maculaire cystoïde dans les uvéites
Marc D. de Smet (2011)
10.3109/17435390.2016.1153165
Safety and toxicity of nanomaterials for ocular drug delivery applications
N. Mehra (2016)
10.1055/s-0028-1109653
[Vitreous substitutes as drug release systems].
P. Szurman (2009)
10.1177/2474126416683299
Simultaneous Dexamethasone Intravitreal Implant and Anti-VEGF Therapy for Neovascular Age-Related Macular Degeneration Resistant to Anti-VEGF Monotherapy
Bozho Todorich (2017)
Semantic Scholar Logo Some data provided by SemanticScholar